WELLS FARGO & COMPANY/MN

Position in CELU — Celularity Inc

CIK 72971 SAN FRANCISCO, CA

Position in CELU

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,495

-$1,830 QoQ

Shares Held

2,500

0.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 39 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,774,320 across 417 Biotechnology names. CELU ranks #356 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	749,528	$372,313,040
2	HALO	Halozyme Therapeutics, Inc.	1,390,428	$108,828,797
3	ALNY	Alnylam Pharmaceuticals, Inc.	310,047	$93,333,446
4	REGN	Regeneron Pharmaceuticals, Inc.	140,802	$87,795,677
5	EXEL	Exelixis, Inc.	717,840	$39,057,673
6	RVMD	Revolution Medicines, Inc.	178,780	$33,481,916
7	ARGX	Argenx SE	34,453	$31,964,458
8	INCY	Incyte Corp	255,064	$28,914,053

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,495	2,500	0.0%	Shares	Defined	2026-08-14
2026-03-31	$3,325	2,500	0.0%	Shares	Defined	2026-05-11
2025-12-31	$2,775	2,500	+400.0%	Shares	Defined	2026-02-13
2025-09-30	$1,035	500	-54.8%	Shares	Defined	2025-11-13
2024-03-31	$5,789	1,107	-89.8%	Shares	Defined	2024-05-10
2023-12-31	$2,680	10,852	+0.5%	Shares	Defined	2024-02-09
2023-09-30	$2,397	10,800	+1.4%	Shares	Defined	2023-11-13
2023-06-30	$5,678	10,654	-52.1%	Shares	Defined	2023-08-15
2023-03-31	$13,793	22,248	+120.5%	Shares	Defined	2023-05-12
2022-12-31	$13,013	10,088	-9.8%	Shares	Defined	2023-02-13
2022-09-30	$25,825	11,180	+3227.4%	Shares	Defined	2022-11-14
2022-06-30	$1,142	336	—	Shares	Defined	2022-08-12
2022-03-31	$0	0	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.